Content
Frontiers of Medicine >> 2022, Volume 16, Issue 2 doi: 10.1007/s11684-021-0855-4
Chemotherapy initiation with single-course methotrexate alone or combined with dactinomycin versus multi-course methotrexate for low-risk gestational trophoblastic neoplasia: a multi-centric randomized clinical trial
Abstract
Content